Naranjan S. Dhalla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Naranjan S. Dhalla has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Rana M. Temsah
St. Boniface General Hospital Research Centre
4 shared publicationsThomas Netticadan
University of Manitoba
3 shared publicationsAdel B. Elmoselhi
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6
1 shared publicationAnton Lukas
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba R2H 2A6, Canada
1 shared publicationBohuslav Ostadal
Czech Academy of Sciences Prague
1 shared publicationDonald Chapman
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre and Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada R2H 2A6
1 shared publication
Latest Publications
- 1 December 2005
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 280 (1-2) , 249
Instructions for Authors
- 1 December 2005
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 280 (1-2) , 249
Instructions for Authors
- 1 November 2005
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 279 (1) , 185
Instructions for Authors
- 1 November 2005
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 279 (1) , 185
Instructions for Authors
- 1 January 2004
- Published by Springer Nature
- p. 303-326
Mechanisms of Cardioprotection against Ischemia Reperfusion Injury
- 1 January 2004
- Published by Springer Nature
- p. 303-326
Mechanisms of Cardioprotection against Ischemia Reperfusion Injury
- Open Access
- 1 September 2003
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 285 (3) , H1055-H1063
Preconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts
The aim of this study was to determine whether changes in protein content and/or gene expression of Na+-K+-ATPase subunits underlie its decreased enzyme activity during ischemia and reperfusion. We measured protein and mRNA subunit levels in isolated rat hearts subjected to 30 min of ischemia and 30 min of reperfusion (I/R). The effect of ischemic preconditioning (IP), induced by three cycles of ischemia and reperfusion (10 min each), was also assessed on the molecular changes in Na+-K+-ATPase subunit composition due to I/R. I/R reduced the protein levels of the α2-, α3-, β1-, and β2-isoforms by 71%, 85%, 27%, and 65%, respectively, whereas the α1-isoform was decreased by +-K+-ATPase. IP attenuated the reduction in protein levels of Na+-K+-ATPase α2-, α3-, and β2-isoforms induced by I/R, without affecting the α1- and β1-isoforms. Furthermore, IP prevented the reduction in mRNA levels of Na+-K+-ATPase α2-, α3-, and β1-isoforms following I/R. Similar alterations in protein contents and mRNA levels for the Na+/Ca2+exchanger were seen due to I/R as well as IP. These findings indicate that remodeling of Na+-K+-ATPase may occur because of I/R injury, and this may partly explain the reduction in enzyme activity in ischemic heart disease. Furthermore, IP may produce beneficial effects by attenuating the remodeling of Na+-K+-ATPase and changes in Na+/Ca2+exchanger in hearts after I/R.
- 1 September 2003
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 285 (3) , H1055-H1063
Open AccessPreconditioning attenuates ischemia-reperfusion-induced remodeling of Na+-K+-ATPase in hearts
The aim of this study was to determine whether changes in protein content and/or gene expression of Na+-K+-ATPase subunits underlie its decreased enzyme activity during ischemia and reperfusion. We measured protein and mRNA subunit levels in isolated rat hearts subjected to 30 min of ischemia and 30 min of reperfusion (I/R). The effect of ischemic preconditioning (IP), induced by three cycles of ischemia and reperfusion (10 min each), was also assessed on the molecular changes in Na+-K+-ATPase subunit composition due to I/R. I/R reduced the protein levels of the α2-, α3-, β1-, and β2-isoforms by 71%, 85%, 27%, and 65%, respectively, whereas the α1-isoform was decreased by +-K+-ATPase. IP attenuated the reduction in protein levels of Na+-K+-ATPase α2-, α3-, and β2-isoforms induced by I/R, without affecting the α1- and β1-isoforms. Furthermore, IP prevented the reduction in mRNA levels of Na+-K+-ATPase α2-, α3-, and β1-isoforms following I/R. Similar alterations in protein contents and mRNA levels for the Na+/Ca2+exchanger were seen due to I/R as well as IP. These findings indicate that remodeling of Na+-K+-ATPase may occur because of I/R injury, and this may partly explain the reduction in enzyme activity in ischemic heart disease. Furthermore, IP may produce beneficial effects by attenuating the remodeling of Na+-K+-ATPase and changes in Na+/Ca2+exchanger in hearts after I/R.
- 1 January 2003
- Published by Springer Nature
- p. 149-164
Mechanisms of Cellular Alterations Due to Ischemia-Reperfusion Injury in the Heart
- 1 January 2003
- Published by Springer Nature
- p. 149-164
Mechanisms of Cellular Alterations Due to Ischemia-Reperfusion Injury in the Heart
- 1 January 2003
- Published by Springer Nature
- p. 103-121
Sarcoplasmic Reticulum Gene Expression of Ca2+-Cycling Proteins as a Target for the Treatment of Heart Failure
- 1 January 2003
- Published by Springer Nature
- p. 103-121
Sarcoplasmic Reticulum Gene Expression of Ca2+-Cycling Proteins as a Target for the Treatment of Heart Failure
- Open Access
- 1 April 2002
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (4) , H1461-H1466
Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion
We have previously shown that ischemic preconditioning (IP) improves cardiac performance and sarcoplasmic reticulum (SR) function in hearts subjected to ischemia-reperfusion (I/R). In this study, we examined the effect of IP on I/R-induced changes in gene expression for SR proteins such as the Ca2+release channel, Ca2+pump ATPase, phospholamban, and calsequestrin in the isolated rat heart. Normal isolated rat hearts exposed to three brief cycles of IP (5-min ischemia and 5-min reperfusion) exhibited a significant decrease in the transcript levels of SR genes. Nonpreconditioned I/R hearts when subjected to 30-min ischemia and 30-min reperfusion showed a marked decrease in mRNA levels for the SR proteins compared with normal hearts; this decrease was attenuated by preconditioning. Although hearts subjected to Ca2+paradox (CP) have been shown to exhibit intracellular Ca2+overload and SR dysfunction like those in I/R hearts, virtually nothing is known regarding the effect of CP on cardiac SR gene expression. Accordingly, CP (5-min Ca2+-free perfusion and 30-min reperfusion with normal medium) was observed to produce dramatic changes in SR gene expression, and the heart failed to contract; these alterations were attenuated by IP. Our results show that 1) both I/R and CP depress SR gene expression in the normal heart, 2) IP attenuates I/R- and CP-induced depression in cardiac function and SR gene expression, and 3) intracellular Ca2+overload may play a role in depressing SR gene expression in both I/R and CP hearts.
- 1 April 2002
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (4) , H1461-H1466
Open AccessPreconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion
We have previously shown that ischemic preconditioning (IP) improves cardiac performance and sarcoplasmic reticulum (SR) function in hearts subjected to ischemia-reperfusion (I/R). In this study, we examined the effect of IP on I/R-induced changes in gene expression for SR proteins such as the Ca2+release channel, Ca2+pump ATPase, phospholamban, and calsequestrin in the isolated rat heart. Normal isolated rat hearts exposed to three brief cycles of IP (5-min ischemia and 5-min reperfusion) exhibited a significant decrease in the transcript levels of SR genes. Nonpreconditioned I/R hearts when subjected to 30-min ischemia and 30-min reperfusion showed a marked decrease in mRNA levels for the SR proteins compared with normal hearts; this decrease was attenuated by preconditioning. Although hearts subjected to Ca2+paradox (CP) have been shown to exhibit intracellular Ca2+overload and SR dysfunction like those in I/R hearts, virtually nothing is known regarding the effect of CP on cardiac SR gene expression. Accordingly, CP (5-min Ca2+-free perfusion and 30-min reperfusion with normal medium) was observed to produce dramatic changes in SR gene expression, and the heart failed to contract; these alterations were attenuated by IP. Our results show that 1) both I/R and CP depress SR gene expression in the normal heart, 2) IP attenuates I/R- and CP-induced depression in cardiac function and SR gene expression, and 3) intracellular Ca2+overload may play a role in depressing SR gene expression in both I/R and CP hearts.
- 1 January 2002
- Published by Springer Nature
- p. 239-259
Molecular and Pharmacological Aspects of the Developing Heart
- 1 January 2002
- Published by Springer Nature
- p. 239-259
Molecular and Pharmacological Aspects of the Developing Heart
- 1 January 2002
- Published by Springer Nature
- p. 173-183
Differences in Calcium Handling and Regulatory Mechanisms between Neonatal and Adult Hearts
- 1 January 2002
- Published by Springer Nature
- p. 173-183
Differences in Calcium Handling and Regulatory Mechanisms between Neonatal and Adult Hearts
- 1 January 2002
- Published by Springer Nature
- p. 163-172
Sarcoplasmic Reticulum Function in the Developing Heart
- 1 January 2002
- Published by Springer Nature
- p. 163-172
Sarcoplasmic Reticulum Function in the Developing Heart